APA (7th ed.) Citation

Desai, M. Y., Owens, A., Wolski, K., Geske, J. B., Saberi, S., Wang, A., . . . Sehnert, A. J. (2024). Mavacamten in Obstructive Hypertrophic Cardiomyopathy Patients Referred for Septal Reduction: Health Status Analysis Through Week 56 in VALOR-HCM Trial. Journal of the American College of Cardiology (JACC), 84(11), 1041. https://doi.org/10.1016/j.jacc.2024.06.025

Chicago Style (17th ed.) Citation

Desai, Milind Y., et al. "Mavacamten in Obstructive Hypertrophic Cardiomyopathy Patients Referred for Septal Reduction: Health Status Analysis Through Week 56 in VALOR-HCM Trial." Journal of the American College of Cardiology (JACC) 84, no. 11 (2024): 1041. https://doi.org/10.1016/j.jacc.2024.06.025.

MLA (9th ed.) Citation

Desai, Milind Y., et al. "Mavacamten in Obstructive Hypertrophic Cardiomyopathy Patients Referred for Septal Reduction: Health Status Analysis Through Week 56 in VALOR-HCM Trial." Journal of the American College of Cardiology (JACC), vol. 84, no. 11, 2024, p. 1041, https://doi.org/10.1016/j.jacc.2024.06.025.